Sangamo Therapeutics Stock Forward View
| SGMO Stock | USD 0.40 0.05 14.29% |
Sangamo Stock outlook is based on your current time horizon. Although Sangamo Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Sangamo Therapeutics' systematic risk associated with finding meaningful patterns of Sangamo Therapeutics fundamentals over time.
As of today the rsi of Sangamo Therapeutics' share price is below 20 . This usually implies that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.09) | EPS Estimate Current Year (0.41) | EPS Estimate Next Year (0.23) | Wall Street Target Price 3.8125 | EPS Estimate Current Quarter (0.10) |
Using Sangamo Therapeutics hype-based prediction, you can estimate the value of Sangamo Therapeutics from the perspective of Sangamo Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Sangamo Therapeutics using Sangamo Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Sangamo using crowd psychology based on the activity and movement of Sangamo Therapeutics' stock price.
Sangamo Therapeutics Implied Volatility | 1.79 |
Sangamo Therapeutics' implied volatility exposes the market's sentiment of Sangamo Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Sangamo Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Sangamo Therapeutics stock will not fluctuate a lot when Sangamo Therapeutics' options are near their expiration.
The Naive Prediction forecasted value of Sangamo Therapeutics on the next trading day is expected to be 0.36 with a mean absolute deviation of 0.03 and the sum of the absolute errors of 1.80. Sangamo Therapeutics after-hype prediction price | USD 0.4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Sangamo Therapeutics to cross-verify your projections. Prediction based on Rule 16 of the current Sangamo contract
Based on the Rule 16, the options market is currently suggesting that Sangamo Therapeutics will have an average daily up or down price movement of about 0.11% per day over the life of the 2026-05-15 option contract. With Sangamo Therapeutics trading at USD 0.4, that is roughly USD 4.48E-4 . If you think that the market is fully incorporating Sangamo Therapeutics' daily price movement you should consider acquiring Sangamo Therapeutics options at the current volatility level of 1.79%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-05-15 Sangamo Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Sangamo Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Sangamo Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Sangamo Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Sangamo Therapeutics' open interest, investors have to compare it to Sangamo Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Sangamo Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Sangamo. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Sangamo Therapeutics Additional Predictive Modules
Most predictive techniques to examine Sangamo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Sangamo using various technical indicators. When you analyze Sangamo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Sangamo Therapeutics Cash Forecast
Forecasting financial indicators like cash flow involves analysts applying various statistical methods, techniques, and algorithms. These tools reveal hidden trends within the Sangamo Therapeutics' financial statements to estimate their effects on upcoming price movements.
Cash | First Reported 2000-03-31 | Previous Quarter 38.3 M | Current Value 30.5 M | Quarterly Volatility 63.8 M |
Sangamo Therapeutics Naive Prediction Price Forecast For the 8th of February
Given 90 days horizon, the Naive Prediction forecasted value of Sangamo Therapeutics on the next trading day is expected to be 0.36 with a mean absolute deviation of 0.03, mean absolute percentage error of 0, and the sum of the absolute errors of 1.80.Please note that although there have been many attempts to predict Sangamo Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Sangamo Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Sangamo Therapeutics Stock Forecast Pattern
| Backtest Sangamo Therapeutics | Sangamo Therapeutics Price Prediction | Research Analysis |
Sangamo Therapeutics Forecasted Value
In the context of forecasting Sangamo Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Sangamo Therapeutics' downside and upside margins for the forecasting period are 0 and 8.69, respectively. We have considered Sangamo Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Sangamo Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Sangamo Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 113.4241 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.029 |
| MAPE | Mean absolute percentage error | 0.0663 |
| SAE | Sum of the absolute errors | 1.8003 |
Predictive Modules for Sangamo Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sangamo Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sangamo Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Sangamo Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Sangamo Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Sangamo Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Sangamo Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Sangamo Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Sangamo Therapeutics' historical news coverage. Sangamo Therapeutics' after-hype downside and upside margins for the prediction period are 0.02 and 8.73, respectively. We have considered Sangamo Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Sangamo Therapeutics is abnormally volatile at this time. Analysis and calculation of next after-hype price of Sangamo Therapeutics is based on 3 months time horizon.
Sangamo Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Sangamo Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sangamo Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Sangamo Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.07 | 8.33 | 0.00 | 0.00 | 9 Events / Month | 7 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.40 | 0.40 | 0.00 |
|
Sangamo Therapeutics Hype Timeline
Sangamo Therapeutics is at this time traded for 0.40. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Sangamo is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is expected to be very small, whereas the daily expected return is at this time at -0.07%. %. The volatility of related hype on Sangamo Therapeutics is about 49000.0%, with the expected price after the next announcement by competition of 0.40. About 19.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.45. Sangamo Therapeutics had not issued any dividends in recent years. Given the investment horizon of 90 days the next expected press release will be in about 9 days. Check out Historical Fundamental Analysis of Sangamo Therapeutics to cross-verify your projections.Sangamo Therapeutics Related Hype Analysis
Having access to credible news sources related to Sangamo Therapeutics' direct competition is more important than ever and may enhance your ability to predict Sangamo Therapeutics' future price movements. Getting to know how Sangamo Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Sangamo Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CCCC | C4 Therapeutics | (0.08) | 8 per month | 0.00 | (0.1) | 8.06 | (7.83) | 25.16 | |
| IMDX | Insight Molecular Diagnostics | (0.12) | 10 per month | 4.19 | 0.06 | 9.42 | (6.67) | 22.08 | |
| OABI | OmniAb Inc | 0.02 | 10 per month | 2.56 | 0.05 | 7.97 | (5.31) | 15.55 | |
| CDXS | Codexis | 0.09 | 9 per month | 0.00 | (0.14) | 6.21 | (8.20) | 22.77 | |
| ARMP | Armata Pharmaceuticals | (0.22) | 8 per month | 5.88 | 0.12 | 14.73 | (8.33) | 38.51 | |
| MIST | Milestone Pharmaceuticals | 0.04 | 8 per month | 0.00 | (0.03) | 6.15 | (6.38) | 34.31 | |
| RANI | Rani Therapeutics Holdings | 0.02 | 8 per month | 0.00 | (0.15) | 9.28 | (8.96) | 26.23 | |
| IPHA | Innate Pharma | (0.03) | 7 per month | 0.00 | (0.04) | 3.41 | (3.87) | 39.49 | |
| MOLN | Molecular Partners AG | 0.27 | 7 per month | 3.29 | 0.05 | 4.77 | (5.45) | 26.47 | |
| IVVD | Invivyd | (0.16) | 10 per month | 5.62 | 0.02 | 11.11 | (8.57) | 46.37 |
Other Forecasting Options for Sangamo Therapeutics
For every potential investor in Sangamo, whether a beginner or expert, Sangamo Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Sangamo Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Sangamo. Basic forecasting techniques help filter out the noise by identifying Sangamo Therapeutics' price trends.Sangamo Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sangamo Therapeutics stock to make a market-neutral strategy. Peer analysis of Sangamo Therapeutics could also be used in its relative valuation, which is a method of valuing Sangamo Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Sangamo Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Sangamo Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sangamo Therapeutics shares will generate the highest return on investment. By undertsting and applying Sangamo Therapeutics stock market strength indicators, traders can identify Sangamo Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 995129.0 | |||
| Daily Balance Of Power | 1.25 | |||
| Rate Of Daily Change | 1.14 | |||
| Day Median Price | 0.38 | |||
| Day Typical Price | 0.39 | |||
| Price Action Indicator | 0.045 | |||
| Period Momentum Indicator | 0.05 |
Sangamo Therapeutics Risk Indicators
The analysis of Sangamo Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Sangamo Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting sangamo stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.96 | |||
| Standard Deviation | 8.34 | |||
| Variance | 69.61 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Sangamo Therapeutics
The number of cover stories for Sangamo Therapeutics depends on current market conditions and Sangamo Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Sangamo Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Sangamo Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Sangamo Therapeutics Short Properties
Sangamo Therapeutics' future price predictability will typically decrease when Sangamo Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Sangamo Therapeutics often depends not only on the future outlook of the potential Sangamo Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sangamo Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 201.7 M | |
| Cash And Short Term Investments | 41.9 M |
Check out Historical Fundamental Analysis of Sangamo Therapeutics to cross-verify your projections. To learn how to invest in Sangamo Stock, please use our How to Invest in Sangamo Therapeutics guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Will Biotechnology sector continue expanding? Could Sangamo diversify its offerings? Factors like these will boost the valuation of Sangamo Therapeutics. If investors know Sangamo will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Sangamo Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.45) | Revenue Per Share | Quarterly Revenue Growth (0.99) | Return On Assets | Return On Equity |
Sangamo Therapeutics's market price often diverges from its book value, the accounting figure shown on Sangamo's balance sheet. Smart investors calculate Sangamo Therapeutics' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Sangamo Therapeutics' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Sangamo Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Sangamo Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sangamo Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.